Crohn's Disease

Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD

A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Stopping PPI Therapy in Inactive IBD

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease